FORMULATION À LIBÉRATION PROLONGÉE DE MÉTHOTREXATE UTILISÉE COMME MÉDICAMENT ANTIRHUMATISMAL MODIFICATEUR DE MALADIE (DMARD) ET AGENT ANTI-CANCÉREUX

• 收藏
• 分享

专利权人:

INC.;PACIRA PHARMACEUTICALS

发明人:

GARCIA, LOUIE, DANIEL,GIBSON, LOIS,LAMBERT, WILLIAM,LI, BENJAMIN,ZHU, LIANGJIN

申请号：

EP11781306

公开号：

EP2568962A4

申请日:

2011.05.12

申请国别(地区):

EP

年份:

2014

代理人:

摘要：

Disclosed is are formulations comprising a multivesicular liposome and MTX, the administration of which results in a Cmax of MTX between 5% and 50% of the Cmax of an immediate release dosage form of MTX, the duration of which lasts from about 1 to about 30 days. Also disclosed are methods of treating autoimmune diseases and cancer by administering these formulations of MTX.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/